Galderma Set for US$2.3 Billion IPO Amid European Market Revival

Galderma Set for US$2.3 Billion IPO Amid European Market Revival

THE WHAT?   Galderma is preparing for a US$2.3 billion IPO on the Swiss stock exchange, aiming to use most of the proceeds for debt repayment and refinancing. The company, with a history as a Nestlé and L’Oréal joint venture and later acquired by EQT, is valued at around US$20 billion.

THE DETAILS  The company’s move to go public signals a recovering European IPO market, with Galderma’s growth in specialized skincare products and successful “blockbuster franchises” driving its decision. Despite a recent downturn in IPO proceeds in Europe, Galderma and other companies are moving forward with listing plans, indicating a potential market revival.

THE WHY?  Galderma reported over US$4 billion in sales last year, a nearly 9% increase, with significant EBITDA, showcasing its industry leadership. The IPO involves selling shares, including those of existing investors, coordinated by major financial institutions, highlighting Galderma’s strategic growth and financial health.

WELLNESS

FASHION

TRAVEL

PROFESSIONAL BEAUTY

JOBS & PEOPLE